nach oben

Tumor Biology

Erschienen in:

30.07.2016 | Original Article

Inhibition on Numb/Notch signal pathway enhances radiosensitivity of lung cancer cell line H358

verfasst von: Shi-Gang Song, Hong-Yang Yu, Yan-Wei Ma, Feng Zhang, Xiang-Ying Xu

Erschienen in: Tumor Biology | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

The objective of the study is to investigate the effects of the Numb/Notch signal pathway on the radiosensitivity of lung cancer cell line H358. MTT assay and colony forming assay were used to detect the effects of different doses of X-rays and MW167 on the in vitro proliferation of the lung cancer cell line H358. Flow cytometry was applied to evaluate the effects of X rays on the apoptosis of H358. Scratch assay and Transwell invasion assay were used to examine the effects of X-rays on the migration and invasion abilities of H358. The mRNA and protein expressions in the signal pathway were detected by real-time PCR and western blot. Assays in vitro confirmed the effects of the Numb/Notch pathway inhibitor on the radiosensitivity to lung cancer. MW167 enhanced the inhibiting effects of X-ray on the proliferation of H358 cell line. After the addition of MW167, the apoptosis rates significantly increased, but the invasion and migration abilities decreased significantly. Meanwhile, MW167 could dose-dependently promote the increase of expression of Numb, which is the upstream gene of the Numb/Notch signaling pathway, but inhibit the expression of and HES1. In vivo experiments revealed that cell proliferation was suppressed in the radiation, pathway inhibitor, and pathway inhibitor + radiation groups, and the pathway inhibitor + radiation group exhibited more active anti-tumor ability when compared with the blank group (all P < 0.05); Numb expression was up-regulated, but Notch1 and HES1 expressions were down-regulated in those three groups, and also, the pathway inhibitor + radiation group exhibited more significant alternation when compared with the blank group (all P < 0.05); cell apoptosis was promoted in those three groups, and the pathway inhibitor + radiation group showed more active apoptosis when compared with the blank group (all P < 0.05). Repression of the Numb/Notch pathway enhances the effects of radiotherapy on the radiosensitivity of the lung cancer cell line H358, and thus the Numb/Notch pathway may be a new target of radiotherapy for lung cancer.

Wang GF, Lai MD, Chen PH. Correlation of multiple primary lung cancer with bronchial and alveolar epithelial dysplasia. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2005;34(5):427–31.PubMed

Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.CrossRefPubMed

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.CrossRefPubMed

Xie SS, Li M, Zhou CC, Song XL, Wang CH. Prophylactic cranial irradiation may impose a detrimental effect on overall survival of patients with nonsmall cell lung cancer: a systematic review and meta-analysis. PLoS One. 2014;9(7):e103431.CrossRefPubMedPubMedCentral

Hillman GG, Singh-Gupta V, Runyan L, Yunker CK, Rakowski JT, Sarkar FH, et al. Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injury. Radiother Oncol. 2011;101(2):329–36.CrossRefPubMedPubMedCentral

Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem. 2004;73:39–85.CrossRefPubMed

Brognard J, Clark AS, Ni Y, Dennis PA. Akt/protein kinase b is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res. 2001;61(10):3986–97.PubMed

Wang XC, LQ D, Tian LL, HL W, Jiang XY, Zhang H, et al. Expression and function of mirna in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer. Lung Cancer. 2011;72(1):92–9.CrossRefPubMed

Zhou C, YL W, Chen G, Feng J, Liu XQ, Wang C, et al. Erlotinib versus chemotherapy as first-line treatment for patients with advanced egfr mutation-positive non-small-cell lung cancer (optimal, ctong-0802): a multicentre, open-label, randomised, phase 3 study. Lancet Oncol. 2011;12(8):735–42.CrossRefPubMed

10.

Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584–94.CrossRefPubMedPubMedCentral

11.

Wharton KA, Johansen KM, Xu T, Artavanis-Tsakonas S. Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing egf-like repeats. Cell. 1985;43(3 Pt 2):567–81.CrossRefPubMed

12.

Kidd S, Kelley MR, Young MW. Sequence of the notch locus of Drosophila melanogaster: relationship of the encoded protein to mammalian clotting and growth factors. Mol Cell Biol. 1986;6(9):3094–108.CrossRefPubMedPubMedCentral

13.

Lai EC. Notch signaling: control of cell communication and cell fate. Development. 2004;131(5):965–73.CrossRefPubMed

14.

Leong KG, Karsan A. Recent insights into the role of notch signaling in tumorigenesis. Blood. 2006;107(6):2223–33.CrossRefPubMed

15.

Zhang XP, Zheng G, Zou L, Liu HL, Hou LH, Zhou P, et al. Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells. Mol Cell Biochem. 2008;307(1–2):101–8.PubMed

16.

Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS. Role of notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res. 2004;6(6):R605–15.CrossRefPubMedPubMedCentral

17.

Dho SE, French MB, Woods SA, McGlade CJ. Characterization of four mammalian numb protein isoforms. Identification of cytoplasmic and membrane-associated variants of the phosphotyrosine binding domain. J Biol Chem. 1999;274(46):33097–104.CrossRefPubMed

18.

Pece S, Confalonieri S, RR P, Di Fiore PP. Numbing down cancer by more than just a notch. Biochim Biophys Acta. 2011;1815(1):26–43.PubMed

19.

Gulino A, Di Marcotullio L, Screpanti I. The multiple functions of numb. Exp Cell Res. 2010;316(6):900–6.CrossRefPubMed

20.

Tosoni D, Zecchini S, Coazzoli M, Colaluca I, Mazzarol G, Rubio A, et al. The numb/p53 circuitry couples replicative self-renewal and tumor suppression in mammary epithelial cells. J Cell Biol. 2015;211(4):845–62.CrossRefPubMedPubMedCentral

21.

Katoh M, Katoh M. Numb is a break of Wnt-notch signaling cycle. Int J Mol Med. 2006;18(3):517–21.PubMed

22.

Westhoff B, Colaluca IN, D’Ario G, Donzelli M, Tosoni D, Volorio S, et al. Alterations of the notch pathway in lung cancer. Proc Natl Acad Sci U S A. 2009;106(52):22293–8.CrossRefPubMedPubMedCentral

23.

Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, Miele L. Rational targeting of notch signaling in cancer. Oncogene. 2008;27(38):5124–31.CrossRefPubMed

24.

Cook J. Radiation sensitization of mammalian cells by metal chelators. Radiat Res. 2001;155(2):304–10.CrossRefPubMed

25.

Jia S, Zhang S, Yuan H, Chen N. Lunasin inhibits cell proliferation via apoptosis and reduces the production of proinflammatory cytokines in cultured rheumatoid arthritis synovial fibroblasts. Biomed Res Int. 2015;2015:346839.PubMedPubMedCentral

26.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in globocan 2012. Int J Cancer. 2015;136(5):E359–86.CrossRefPubMed

27.

Meder L, Konig K, Ozretic L, Schultheis AM, Ueckeroth F, Ade CP, et al. Notch, ascl1, p53 and rb alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas. Int J Cancer. 2016;138(4):927–38.CrossRefPubMed

28.

Wood PA, Yang X, Hrushesky WJ. Clock genes and cancer. Integr Cancer Ther. 2009;8(4):303–8.CrossRefPubMed

29.

Wang G, Mao W, Zheng S, Ye J. Epidermal growth factor receptor-regulated mir-125a-5p—a metastatic inhibitor of lung cancer. FEBS J. 2009;276(19):5571–8.CrossRefPubMedPubMedCentral

30.

Cron KR, Zhu K, Kushwaha DS, Hsieh G, Merzon D, Rameseder J, et al. Proteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancer. PLoS One. 2013;8(9):e73710.CrossRefPubMedPubMedCentral

31.

Jiang L, Chang J, Zhang Q, Sun L, Qiu X. MicroRNA hsa-mir-125a-3p activates p53 and induces apoptosis in lung cancer cells. Cancer Investig. 2013;31(8):538–44.CrossRef

32.

Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage iiia or iiib non-small-cell lung cancer (rtog 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015;16(2):187–99.CrossRefPubMedPubMedCentral

33.

Yan B, Omar FM, Das K, Ng WH, Lim C, Shiuan K, et al. Characterization of numb expression in astrocytomas. Neuropathology. 2008;28(5):479–84.CrossRefPubMed

34.

Zhao YJ, Han HZ, Liang Y, Shi CZ, Zhu QC, Yang J. Alternative splicing of VEGFA, app and numb genes in colorectal cancer. World J Gastroenterol. 2015;21(21):6550–60.CrossRefPubMedPubMedCentral

35.

Wang C, Feng W, Zhang C. The expression and function of numb in endometrial cancer and the interaction with hdm2 and p53. J Cancer. 2015;6(10):1030–40.CrossRefPubMedPubMedCentral

36.

Zhang XM, Wang JX, Lei XG, Cheng H, Wang LL, Yao GY. Regulation and mechanism of notch signaling pathway in small cell lung cancer. Zhonghua Bing Li Xue Za Zhi. 2010;39(2):95–9.PubMed

37.

McGill MA, Dho SE, Weinmaster G, McGlade CJ. Numb regulates post-endocytic trafficking and degradation of notch1. J Biol Chem. 2009;284(39):26427–38.CrossRefPubMedPubMedCentral

38.

Zhou P, Alfaro J, Chang EH, Zhao X, Porcionatto M, Segal RA. Numb links extracellular cues to intracellular polarity machinery to promote chemotaxis. Dev Cell. 2011;20(5):610–22.CrossRefPubMedPubMedCentral

39.

Nickoloff BJ, Qin JZ, Chaturvedi V, Denning MF, Bonish B, Miele L. Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through nf-kappab and PPAR-gamma. Cell Death Differ. 2002;9(8):842–55.CrossRefPubMed

40.

Pitsouli C, Delidakis C. The interplay between DSL proteins and ubiquitin ligases in notch signaling. Development. 2005;132(18):4041–50.CrossRefPubMed

41.

Okajima T, Irvine KD. Regulation of notch signaling by o-linked fucose. Cell. 2002;111(6):893–904.CrossRefPubMed

42.

Gordon WR, Vardar-Ulu D, Histen G, Sanchez-Irizarry C, Aster JC, Blacklow SC. Structural basis for autoinhibition of notch. Nat Struct Mol Biol. 2007;14(4):295–300.CrossRefPubMed

43.

Brou C, Logeat F, Gupta N, Bessia C, LeBail O, Doedens JR, et al. A novel proteolytic cleavage involved in notch signaling: the role of the disintegrin-metalloprotease tace. Mol Cell. 2000;5(2):207–16.CrossRefPubMed

44.

Miele L, Golde T, Osborne B. Notch signaling in cancer. Curr Mol Med. 2006;6(8):905–18.CrossRefPubMed

45.

Gupta-Rossi N, Six E, LeBail O, Logeat F, Chastagner P, Olry A, et al. Monoubiquitination and endocytosis direct gamma-secretase cleavage of activated notch receptor. J Cell Biol. 2004;166(1):73–83.CrossRefPubMedPubMedCentral

46.

Nam Y, Sliz P, Pear WS, Aster JC, Blacklow SC. Cooperative assembly of higher-order notch complexes functions as a switch to induce transcription. Proc Natl Acad Sci U S A. 2007;104(7):2103–8.CrossRefPubMedPubMedCentral

47.

Yao J, Duan L, Fan M, X W. Gamma-secretase inhibitors exerts antitumor activity via down-regulation of notch and nuclear factor kappa b in human tongue carcinoma cells. Oral Dis. 2007;13(6):555–63.CrossRefPubMed

48.

Zhou M, Fan Z, Han R. Influence of blocking notch signaling pathway by γ-secretase inhibitor on proliferation of lung adenocarcinoma a549 cells. J Shanghai Jiaotong Univ (Med Sci). 2012;8(021).

49.

Mizugaki H, Sakakibara-Konishi J, Ikezawa Y, Kikuchi J, Kikuchi E, Oizumi S, et al. Gamma-secretase inhibitor enhances antitumour effect of radiation in notch-expressing lung cancer. Br J Cancer. 2012;106(12):1953–9.CrossRefPubMedPubMedCentral

50.

Kang J, Kim E, Kim W, Seong KM, Youn H, Kim JW, et al. Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (emt) by mir-34a-mediated suppression of notch-1 expression in non-small cell lung cancer cell lines. J Biol Chem. 2013;288(38):27343–57.CrossRefPubMedPubMedCentral

51.

Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, et al. Notch promotes radioresistance of glioma stem cells. Stem Cells. 2010;28(1):17–28.PubMedPubMedCentral

Titel: Inhibition on Numb/Notch signal pathway enhances radiosensitivity of lung cancer cell line H358
verfasst von: Shi-Gang Song
Hong-Yang Yu
Yan-Wei Ma
Feng Zhang
Xiang-Ying Xu
Publikationsdatum: 30.07.2016
Verlag: Springer Netherlands
Erschienen in: Tumor Biology / Ausgabe 10/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-016-5134-7

Springer Medizin

Inhibition on Numb/Notch signal pathway enhances radiosensitivity of lung cancer cell line H358

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2016

Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases

Interleukin-6 receptor in spindle-shaped stromal cells, a prognostic determinant of early breast cancer

miRNA-regulated cancer stem cells: understanding the property and the role of miRNA in carcinogenesis

CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy

Extracellular HSP70-peptide complexes promote the proliferation of hepatocellular carcinoma cells via TLR2/4/JNK1/2MAPK pathway

Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie